Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Nivolumab and ipilimumab thera...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Nivolumab and ipilimumab therapy in a patient with non-small cell lung cancer with chronic kidney disease

Nivolumab and ipilimumab therapy in a patient with non-small cell lung cancer with chronic kidney disease

Bibliographic Details
Main Authors: Hiroaki Satoh, Sou Hattori
Format: Article
Language:English
Published: Termedia Publishing House 2022-06-01
Series:Contemporary Oncology
Subjects:
nivolumab
ipilimumab
non-small cell lung cancer
chronic kidney disease.
Online Access:https://www.termedia.pl/Nivolumab-and-ipilimumab-therapy-in-a-patient-with-non-small-cell-lung-cancer-with-chronic-kidney-disease,3,47466,1,1.html
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://www.termedia.pl/Nivolumab-and-ipilimumab-therapy-in-a-patient-with-non-small-cell-lung-cancer-with-chronic-kidney-disease,3,47466,1,1.html

Similar Items

  • Cost-Effectiveness of Nivolumab Plus Ipilimumab With and Without Chemotherapy for Advanced Non-Small Cell Lung Cancer
    by: Szu-Chun Yang, et al.
    Published: (2021-12-01)
  • Cost-Effectiveness of Nivolumab Plus Ipilimumab as First-Line Therapy in Advanced Non–small-cell Lung Cancer
    by: Xuezhi Hao, et al.
    Published: (2021-07-01)
  • Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab vs. Chemotherapy as First-Line Therapy in Advanced Non-Small Cell Lung Cancer
    by: Huabin Hu, et al.
    Published: (2020-09-01)
  • Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab for Advanced Non-Small-Cell Lung Cancer
    by: Xiaomin Wan, et al.
    Published: (2021-08-01)
  • Ipilimumab and nivolumab for recurrent neuroendocrine cervical carcinoma
    by: Mary Towner, et al.
    Published: (2022-08-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs